332 related articles for article (PubMed ID: 21229642)
61. Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo.
Wang L; Long L; Wang W; Liang Z
J Pharmacol Sci; 2015 Dec; 129(4):216-25. PubMed ID: 26698406
[TBL] [Abstract][Full Text] [Related]
62. Bevacizumab as secondline treatment of glioblastoma - worth the effort?
Rovere RK
Klin Onkol; 2014; 27(3):219-20. PubMed ID: 24918282
[TBL] [Abstract][Full Text] [Related]
63. Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme.
Simon JM; Noël G; Chiras J; Hoang-Xuan K; Delattre JY; Baillet F; Mazeron JJ
Radiother Oncol; 2003 Apr; 67(1):45-51. PubMed ID: 12758239
[TBL] [Abstract][Full Text] [Related]
64. Establishment of a new human glioblastoma multiforme cell line (WJ1) and its partial characterization.
Wang J; Wang X; Jiang S; Lin P; Zhang J; Wu Y; Xiong Z; Ren JJ; Yang H
Cell Mol Neurobiol; 2007 Nov; 27(7):831-43. PubMed ID: 17703357
[TBL] [Abstract][Full Text] [Related]
65. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
[TBL] [Abstract][Full Text] [Related]
66. The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma.
Karsy M; Albert L; Murali R; Jhanwar-Uniyal M
Tumour Biol; 2014 May; 35(5):4567-80. PubMed ID: 24399651
[TBL] [Abstract][Full Text] [Related]
67. Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model.
Mathieu V; De Nève N; Le Mercier M; Dewelle J; Gaussin JF; Dehoux M; Kiss R; Lefranc F
Neoplasia; 2008 Dec; 10(12):1383-92. PubMed ID: 19048117
[TBL] [Abstract][Full Text] [Related]
68. DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma.
Roberto GM; Paiva HH; Botelho de Souza LE; Pezuk JA; Vieira GM; de Oliveira HF; Umezawa K; Tone LG; Brassesco MS
Anticancer Agents Med Chem; 2018; 18(9):1323-1329. PubMed ID: 29683097
[TBL] [Abstract][Full Text] [Related]
69. Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
Hardee ME; Marciscano AE; Medina-Ramirez CM; Zagzag D; Narayana A; Lonning SM; Barcellos-Hoff MH
Cancer Res; 2012 Aug; 72(16):4119-29. PubMed ID: 22693253
[TBL] [Abstract][Full Text] [Related]
70. [Our experience with targeted therapy in glioblastoma multiforme].
Kiss E; Lahm E; Vachaja J; Nagy P; Bazsó P; Fekete Z; Takácsi-Nagy Z; Pápai Z
Magy Onkol; 2013 Dec; 57(4):264-8. PubMed ID: 24353992
[TBL] [Abstract][Full Text] [Related]
71. High density is a property of slow-cycling and treatment-resistant human glioblastoma cells.
Sabelström H; Quigley DA; Fenster T; Foster DJ; Fuchshuber CAM; Saxena S; Yuan E; Li N; Paterno F; Phillips JJ; James CD; Norling B; Berger MS; Persson AI
Exp Cell Res; 2019 May; 378(1):76-86. PubMed ID: 30844389
[TBL] [Abstract][Full Text] [Related]
72. Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma.
Barone A; Sengupta R; Warrington NM; Smith E; Wen PY; Brekken RA; Romagnoli B; Douglas G; Chevalier E; Bauer MP; Dembowsky K; Piwnica-Worms D; Rubin JB
Oncotarget; 2014 Oct; 5(20):9811-22. PubMed ID: 25238146
[TBL] [Abstract][Full Text] [Related]
73. Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures.
Eimer S; Dugay F; Airiau K; Avril T; Quillien V; Belaud-Rotureau MA; Belloc F
Neuro Oncol; 2012 Dec; 14(12):1441-51. PubMed ID: 23104476
[TBL] [Abstract][Full Text] [Related]
74. Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture.
Burckel H; Josset E; Denis JM; Gueulette J; Slabbert J; Noël G; Bischoff P
Oncol Rep; 2015 Jan; 33(1):471-7. PubMed ID: 25371289
[TBL] [Abstract][Full Text] [Related]
75. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
[TBL] [Abstract][Full Text] [Related]
76. Porfimer-sodium (Photofrin-II) in combination with ionizing radiation inhibits tumor-initiating cell proliferation and improves glioblastoma treatment efficacy.
Benayoun L; Schaffer M; Bril R; Gingis-Velitski S; Segal E; Nevelsky A; Satchi-Fainaro R; Shaked Y
Cancer Biol Ther; 2013 Jan; 14(1):64-74. PubMed ID: 23114641
[TBL] [Abstract][Full Text] [Related]
77. The small molecule drug CBL0137 increases the level of DNA damage and the efficacy of radiotherapy for glioblastoma.
Tallman MM; Zalenski AA; Deighen AM; Schrock MS; Mortach S; Grubb TM; Kastury PS; Huntoon K; Summers MK; Venere M
Cancer Lett; 2021 Feb; 499():232-242. PubMed ID: 33253788
[TBL] [Abstract][Full Text] [Related]
78. Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells.
Aldea MD; Petrushev B; Soritau O; Tomuleasa CI; Berindan-Neagoe I; Filip AG; Chereches G; Cenariu M; Craciun L; Tatomir C; Florian IS; Crivii CB; Kacso G
J BUON; 2014; 19(2):502-11. PubMed ID: 24965413
[TBL] [Abstract][Full Text] [Related]
79. Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab.
Thompson EM; Dosa E; Kraemer DF; Neuwelt EA
J Neurooncol; 2011 Jun; 103(2):353-60. PubMed ID: 20848300
[TBL] [Abstract][Full Text] [Related]
80. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres.
Ding D; Lim KS; Eberhart CG
Acta Neuropathol Commun; 2014 Mar; 2():31. PubMed ID: 24685274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]